Semi-closed hyperthermic-antiblastic peritoneal perfusion (HAPP) in the treatment of peritoneal carcinosis

Journal of Surgical Oncology

Volumn 82, Issue 2, 2003, Pages 138-140

  De Simone, Michele ^a,e   Barone, Riccardo ^b   Vaira, Marco ^a   Aghemo, Bartolomeo ^c   Mioli, Pierroberto ^c   Franco, Carlo ^d   Scuderi, Stefano ^a   Costamagna, Daniela ^a   Dei Poli, Marcello ^b  

^a UNIVERSITY OF TURIN   (Italy)

^b Division of Surgery   (Italy)

^c NONE   (Italy)

^d Azienda Osped S Giovanni Battista   (Italy)

^e UOA Chirurgia d'Urgenza e PS   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSTATIC AGENT;

ARTICLE; HYPERTHERMIC ANTIBLASTIC PERITONEAL PERFUSION; INTERMETHOD COMPARISON; PERITONEAL CARCINOSIS; PERITONEAL DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; SURGICAL TECHNIQUE; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; PERITONEAL NEOPLASMS;

EID: 0037308191     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/jso.10190     Document Type: Article

References (21)

1. Chu DZ, Lang NP, Thompson C, et al.: Peritoneal carcinomatosis in nongynecologic malignancies: A prospective study of prognosis factors. Cancer 1989;2:364-367.
2. De Simone M, Aimone M, Izzo G, et al.: Hyperthermic antiblastic perfusion of the extremities, the pelvic cavity and the peritoneum. Surgical techniques and methods. Initial clinical experience. Panminerva Med 1996;38(suppl 1):28-34.
3. Pestieau SR, Sugarbaker PH: Treatment of primary colon cancer with peritoneal carcinomatosis: Comparison of concomitant vs. delayed management. Dis Colon Rectum 2000;43:1341-1346.
4. Loggie BW, Fleming RA, Mcquellon RP, et al.: Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 2000;66:561-568.
5. Elias D, Antoun S, Raynard B, et al.: Traitement des carcinoses péritonéales par exérèse complète et chimiohyperthermie intrapéritonéale. Etude de phase I-II permettant de définir la meilleure procédure technique. Chirurgie 1999;124:380-389.
6. Cavaliere F, Perri P, Di Filippo F, et al.: Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol 2000;74:41-44.
7. Bartlett DL, Buell JF, Libutti SK, et al.: A phase I trial of continuous hyperthermic peritoneal perfusion with tumor necrosis factor and cisplatin in treatment of peritoneal carcinomatosis. Cancer 1998;83:1251-1261.
8. Yonemura Y, Fujimura T, Fushida S, et al.: Hyperthermochemotherapy for treatment of peritoneal carcinomatosis. In Yonemura Y, editor. "Peritoneal Dissemination: Molecular Mechanisms and the Latest Therapy." Kanazawa, Japan: Maeda Shoten, 1998:237-260.
9. Kobayashi K, Fujimoto S, Takahashi M, et al.: Clinical result of intraperitoneal hyperthermic chemoperfusion for gastric cancer with serosal invasion to prevent peritoneal recurrence. Gan To Kagaku Ryoko 1998;25:1436-1438.
10. Hirose K, Katayama K, Lida A, et al.: Efficacy of continuous hyperthermic peritoneal perfusion for the prophylaxis and treatment of peritoneal metastasis of advanced gastric cancer: Evaluation by multivariate regression analysis. Oncology 1999;57:106-114.
11. Hamazoe R, Maeta M, Kaibara N: Intraperitoneal thermochemotherapy for prevention of peritoneal recurrence of gastric cancer. Final results of a randomized controlled study. Cancer 1994;73:2048-2052.
12. François Y, Grandclément E, Sayag-Beaujard AC, et al.: Chimiohyperthermie intrapéritonéale avec mitomycine C dans les cancers de l'estomac avec carcinose péritonéale. Chirurgie 1997;134:237-242.
13. Steller MA, Egorin MJ, Trimble EL, et al.: A pilot phase I trial of continuous hyperthermic peritoneal perfusion with high-dose Carboplatin as primary treatment of patients with small-volume residual ovarian cancer. Cancer Chemother Pharmacol 1999;43:106-114.
14. Nicoletto MO, Padrini R, Galeotti F, et al.: Pharmacokinetics of intraperitoneal hyperthermic perfusion with mitoxantrone in ovarian cancer. Cancer Chemother Pharmacol 2000;45:457-462.
15. Rossi CR, Pilati P, Mocellin S, et al.: Carcinoma dell'ovaio: Studio pilota sulla perfusione ipertermico-antiblastica intraperitoneale intraoperatoria. Tumori 1999;85(suppl 1):S43-45.
16. Sebbag G, Yan H, Shmookler BM, et al.: Results of treatment of 33 patients with peritoneal mesothelioma. Br J Surg 2000;87:1587-1593.
17. Park BJ, Alexander HR, Libutti SK, et al.: Treatment of primary peritoneal mesothelioma by continuous hyperthermic peritoneal perfusion (CHPP). Ann Surg Oncol 1999;6:582-590.
18. Falk MH, Issels RD: Hyperthermia. Oncol Int J Hyperthermia 2001;17:1-18.
19. Gilly F, Carry PY, Sayag AC, et al.: Regional chemotherapy (with Mitomycin C) and intra-operative hyperthermia for digestive cancer with peritoneal carcinomatosis. Hepatogastroenterology 1994;41:124-129.
20. Fujimura T, Katayama K, Fushida S, et al.: Effect of hyperthermochemotherapy on miscellaneous diseases. In Yonemura Y, editor. "Peritoneal Dissemination: Molecular Mechanisms and the Latest Therapy." Kanazawa, Japan: Maeda Shoten. 1998:267-274.
21. Averbach AM, Sugarbaker PH: Methodologic considerations in treatment using intraperitoneal chemotherapy. In Sugarbaker PH, editor. "Peritoneal Carcinomatosis: Principles of Management." Boston: Kluwer Academic, 1996:289-309.